| Nivolumab BMS | 🇪🇺European Union | | | Withdrawn | Bristol-Myers Squibb Pharma EEIG |
| Opdivo | 🇺🇸United States | 100MG/10ML, 40MG/4ML | injectable | Marketed | Bristol Myers Squibb |
| Opdivo QvantigCombination | 🇺🇸United States | 600MG; 10000UNITS PER5ML | injectable | Marketed | Bristol-Myers Squibb |
| Opdivo | 🇺🇸United States | 120MG/12ML | Injection | Marketed | Bristol-Myers Squibb Company |
| Opdivo | 🇺🇸United States | 100MG/10ML | Injection | Marketed | Bristol-Myers Squibb Company |
| Opdivo | 🇺🇸United States | 240MG/24ML | Injection | Marketed | Bristol-Myers Squibb Company |
| Opdivo QvantigCombination | 🇺🇸United States | 300MG/2.5ML;5,000UNITS/2.5ML | Injection | Marketed | Bristol-Myers Squibb Company |
| Opdivo QvantigCombination | 🇺🇸United States | 600MG; 10000 UNITS PER 5ML | injectable | Marketed | Bristol-Myers Squibb |
| OpdualagCombination | 🇺🇸United States | 240MG; 80MG | solution | Marketed | Bristol Myers Squibb |
| Opdivo | 🇪🇺European Union | | | Authorised | Bristol-Myers Squibb Pharma EEIG |
| Nivdirec | 🇧🇷Brazil | | | Authorised | Bristol-Myers Squibb Farmacêutica Ltda |
| Opdivo 10 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 107 mg/dosis | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Opdivo 10 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 40 mg | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Opdivo 10 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 47 mg/dosis | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Opdivo 10 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 47 mg/dosis | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Opdivo 10 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 10 mg | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Opdivo 10 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 40 mg/dosis | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Opdivo 10 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 100 mg/dosis | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Opdivo 10 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 100 mg | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Opdivo | 🇮🇹Italy | | Concentrato per soluzione per infusione | Authorised | Bristol-Myers Squibb Pharma Eeig |
| Opdivo | 🇮🇹Italy | | Concentrato per soluzione iniettabile | Authorised | Gekofar S.R.L. |
| Opdivo | 🇮🇹Italy | | Concentrato per soluzione iniettabile | Authorised | Abacus Medicine A/S |
| OpdualagCombination | 🇪🇺European Union | | | Authorised | Bristol-Myers Squibb Pharma EEIG |
| Opdivo 600 MG Solucion Inyectable | 🇪🇸Spain | 600 mg | solución inyectable | Authorised | Bristol-Myers Squibb Pharma Eeig |
| Opdivo 600 MG Solucion Inyectable | 🇪🇸Spain | 600 mg | solución inyectable | Authorised | Bristol-Myers Squibb Pharma Eeig |
